@Tsinghua_Uni: Breaking records across all four key benchmarks! Innovative Tsinghua's @AIRTHU1201 and collaborators have unveiled Gala…
Summary
Tsinghua University and AIRTHU introduce GalaxyVS, a method that transforms protein–ligand docking into ultra-large-scale parallel vector retrieval, setting a new global benchmark for high-throughput drug discovery.
View Cached Full Text
Cached at: 07/27/26, 01:52 PM
Breaking records across all four key benchmarks! Innovative Tsinghua’s @AIRTHU1201 and collaborators have unveiled GalaxyVS, transforming protein–ligand docking into ultra-large-scale parallel vector retrieval. This sets a new global benchmark for high-throughput drug discovery. https://t.co/vb2E2yiWDF
Similar Articles
@AlphaSignalAI: A 4B model can now anticipate scientific breakthroughs before scientists do. Researchers often build breakthroughs by c…
A new paper introduces GIANTS-4B, a 4-billion-parameter model trained with reinforcement learning to predict scientific insights by combining ideas from foundational papers, achieving higher similarity and citation potential than larger models like Gemini 3 Pro.
Xiaomi just claimed 1,000+ tps on a 1T model using a standard 8-GPU server
Xiaomi released MiMo-V2.5-Pro-UltraSpeed in collaboration with TileRT, achieving over 1000 tokens/s decode speed on a 1-trillion-parameter model, enabling real-time AI interaction and accelerating coding agents and reasoning tasks.
@alex_verem: a team of researchers just proved you don't need a bigger model, you need a smarter plan researchers from Tsinghua and …
Researchers from Tsinghua and South China University of Technology introduced Atomic Task Graph (ATG), a framework that enables 7B-8B open-source models to surpass GPT-4 on complex agent benchmarks without fine-tuning, by using directed graph-based planning and internal simulation to drastically reduce hallucination rates.
@nablabio: Today, we expand zero-shot drug design beyond binding to the design of multifunctional medicines, the intracellular pro…
Nabla Bio unveils JAM-2, a model for zero-shot drug design achieving atomic-precision, computationally designed multispecific antibodies and dual-variant KRAS multispecifics with high potency and selectivity, validated with Cryo-EM and wet-lab experiments.
@charles_irl: Many are belatedly realizing that intelligence must be open. For open intelligence to succeed, developers must work tog…
A collaboration between Modal, SGLang, and Z Lab integrates DFlash speculation into SGLang, achieving up to 4.3x throughput improvement for Alibaba's Qwen 397B-A17B model, advancing open intelligence.